Suscribirse

Genome-wide meta-analysis implicates variation affecting mast cell biology in urticaria - 05/02/24

Doi : 10.1016/j.jaci.2023.08.033 
Sheila Mary McSweeney, MB, MSc a, , Jake Saklatvala, PhD b, Rossella Rispoli, MSc b, Clarisse Ganier, PhD c, Grzegorz Woszczek, MD, PhD d, Laurent Thomas, PhD e, f, g, Kristian Hveem, MD, PhD e, h, i, Mari Løset, MD, PhD e, j, Nick Dand, PhD b, , Christos Tziotzios, MB BChir (Cantab), PhD, FHEA, FRCP a, , Michael Simpson, PhD b, , John Alexander McGrath, MD, FRCP, FmedSci a,
a St. John’s Institute of Dermatology, London, United Kingdom 
b Department of Medical and Molecular Genetics, King’s College London, London, United Kingdom 
c Center of Gene Therapy and Regenerative Medicine, King’s College London, London, United Kingdom 
d School of Immunology and Microbial Sciences, King’s College London, London, United Kingdom 
e K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway 
f Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway 
g BioCore - Bioinformatics Core Facility, Norwegian University of Science and Technology, Trondheim, Norway 
h HUNT Research Centre, Department of Public Health and Nursing, Norwegian University of Science and Technology, Levanger, Norway 
i Levanger Hospital, Nord-Trøndelag Hospital Trust, Trondheim University Hospital, Trondheim, Norway 
j Department of Dermatology, Clinic of Orthopedics, Rheumatology and Dermatology, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway 

Corresponding author: Sheila Mary McSweeney, MB, MSc, 9th Floor, Tower Wing, Guy’s Hospital, Great Maze Pond, London SE1 9RT.9th FloorTower WingGuy’s HospitalGreat Maze PondLondonSE1 9RT

Abstract

Background

Urticaria is characterized by inappropriate mast cell degranulation leading to the development of wheals and/or angioedema. Twin and family studies indicate that there is a substantial heritable component to urticaria risk.

Objective

Our aim was to identify genomic loci at which common genetic variation influences urticaria susceptibility.

Methods

Genome-wide association studies of urticaria (including all subtypes) from 3 European cohorts (UK Biobank, FinnGen, and the Trøndelag Health Study [HUNT]) were combined through statistical meta-analysis (14,306 urticaria cases and 650,664 controls). Cases were identified via electronic health care records from primary and/or secondary care. To identify putative causal variants and genes, statistical fine-mapping, colocalization, and interrogation of publicly available single-cell transcriptome sequencing resources were performed.

Results

Genome-wide significant associations (P < 5 × 10–8) were identified at 6 independent loci. These included 2 previously reported association signals at 1q44 and the human leucocyte antigen region on chromosome 6. Genes with expected or established roles in mast cell biology were associated with the 4 other genome-wide association signals (GCSAML, FCER1A, TPSAB1, and CBLB). Colocalization of association signals consistent with the presence of shared causal variants was observed between urticaria susceptibility and increased expression of GCSAML (posterior probability of colocalization [PPcoloc] = 0.89) and FCER1A (PPcoloc = 0.91) in skin.

Conclusion

Common genetic variation influencing the risk of developing urticaria was identified at 6 genomic loci. The relationship between genes with roles in mast cell biology and several association signals implicates genetic variability of specific components of mast cell function in the development of urticaria.

El texto completo de este artículo está disponible en PDF.

Key words : Urticaria, mast cells, meta-analysis, genome-wide association study

Abbreviations used : CACNA1H, CSU, CU, GWAS, HUNT, OR, PP, PPcoloc, QTL, TPSAB1


Esquema


© 2023  The Authors. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 153 - N° 2

P. 521 - février 2024 Regresar al número
Artículo precedente Artículo precedente
  • Single-cell transcriptomics reveals granzyme K–expressing cytotoxic Tfh cells in tertiary lymphoid structures in IgG4-RD
  • Ryuichi Aoyagi, Takashi Maehara, Risako Koga, Ryusuke Munemura, Tadashi Tomonaga, Yuka Murakami, Atsushi Doi, Hidetaka Yamamoto, Tamotsu Kiyoshima, Shintaro Kawano, Seiji Nakamura
| Artículo siguiente Artículo siguiente
  • Nasal polyp antibody-secreting cells display proliferation signature in aspirin-exacerbated respiratory disease
  • Aaqib Sohail, Jonathan Hacker, Tessa Ryan, Alanna McGill, Regan Bergmark, Neil Bhattacharyya, Stella E. Lee, Alice Maxfield, Rachel Roditi, Amélie M. Julé, Alec Griffith, James Lederer, Tanya M. Laidlaw, Kathleen M. Buchheit

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.